1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Daniela Matei, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer Sorafenib, Topotecan - Ovarian Cancer | Phase 1 / Phase 2 | Terminated | Daniela Matei, MD | 30 | 2007-09-01 | 2016-03-03 |
United States (1)